<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04592185</url>
  </required_header>
  <id_info>
    <org_study_id>EPI-EFA</org_study_id>
    <nct_id>NCT04592185</nct_id>
  </id_info>
  <brief_title>The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms</brief_title>
  <acronym>EPI-EFA</acronym>
  <official_title>Post-registration Observational Study on the Custom-made Abdominal Aortic Endograft Fenestrated Anaconda™</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vascutek Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federation of Medical Specialties</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vascutek Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The French Ministry registered the Fenestrated Anaconda ™ on the List of Reimbursable&#xD;
      Products and Services (LPPR) by the French Health Insurance on February 2018 for a duration&#xD;
      of 5 years, while taking up the conditions for carrying out the act recommended by the&#xD;
      CNEDiMTS (Committee in charge of medical device review), namely the carrying out of a&#xD;
      post-registration study for the renewal of the authorization. This renewal of registration is&#xD;
      conditioned by the set-up of a long-term follow-up study of all patients treated with the&#xD;
      Fenestrated Anaconda ™ in France.&#xD;
&#xD;
      To do this, this study will be carried out in partnership with the Federation of Medical&#xD;
      Specialties (FSM) and the National Professional Council (CNP) of Vascular Surgery in order to&#xD;
      have the data necessary for the renewal of the registration of the Fenestrated Anaconda ™&#xD;
      from the registry called Datavasc developed by the CNP and available online on the FSM's&#xD;
      electronic platform.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EPI-EFA study: Post-registration study of the Fenestrated Anaconda™ in the management of a&#xD;
      complex abdominal, juxtarenal, pararenal, suprarenal aortic aneurysm, whether or not&#xD;
      associated with a distal common iliac artery or thoracoabdominal aneurysm type IV, in&#xD;
      high-risk patients requiring treatment, for whom a surgical contraindication has been asked.&#xD;
&#xD;
        -  Study type : observational, national, multi-centre, prospective, non-comparative study,&#xD;
           as open registry&#xD;
&#xD;
        -  Primary objective : To evaluate the long-term interest of Fenestrated Anaconda™ on all&#xD;
           patients treated with in France. The data collected should be:&#xD;
&#xD;
        -  1-year mortality rate related to device, procedure, any cause = primary endpoint&#xD;
&#xD;
        -  Stent-related adverse events (endoleak, migration, integrity of the device), renal&#xD;
           events, ischemia (medullary (paraplegia / paraparesis), intestinal) = secondary&#xD;
           endpoints&#xD;
&#xD;
        -  Study timelines :&#xD;
&#xD;
        -  Duration / follow-up :&#xD;
&#xD;
        -  1-year recruitment period from October 2019, with a minimum of 91 patients&#xD;
&#xD;
        -  Mid-term follow-up : at 1 year&#xD;
&#xD;
        -  Routine practice : until 5 years&#xD;
&#xD;
        -  Reports to be submitted to French Health Authority :&#xD;
&#xD;
        -  Interim report with mid-term follow-up data for renewal dossier&#xD;
&#xD;
        -  Final report with long-term follow-up data&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 21, 2019</start_date>
  <completion_date type="Anticipated">October 2025</completion_date>
  <primary_completion_date type="Actual">October 15, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Long-term outcome of use of Fenestrated Anaconda</measure>
    <time_frame>1 year</time_frame>
    <description>Device-related mortality, procedure-related mortality, all-cause mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stent-related adverse events</measure>
    <time_frame>5 years</time_frame>
    <description>Endoleak, migration, integrity of device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal adverse events</measure>
    <time_frame>5 years</time_frame>
    <description>Renal adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemia</measure>
    <time_frame>5 years</time_frame>
    <description>Medullary (paraplegia/paraparesis), intestinal</description>
  </secondary_outcome>
  <enrollment type="Actual">106</enrollment>
  <condition>Vascular Diseases</condition>
  <condition>Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fenestrated Anaconda™ Device</intervention_name>
    <description>Treatment of complex abdominal aortic aneurysms</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        In order to meet the French Health Authority (HAS) requirements, this study aims to include&#xD;
        all patients treated with the Fenestrated Anaconda™ under real conditions of use in France.&#xD;
&#xD;
        These patients must have a preoperative morphological assessment favourable to the&#xD;
        placement of a fenestrated endoprosthesis. The affected patients are considered at high&#xD;
        risk.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        At the request of the French Health Authority (HAS), no inclusion or exclusion criteria can&#xD;
        be set as the study should be carried out on all patients treated with the device in&#xD;
        France.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pr. Jean-Noël Albertini</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de ST-ETIENNE- Hôpital Nord, SAINT-PRIEST-EN-JAREZ</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHR de METZ-THIONVILLE - Hôpital de Mercy</name>
      <address>
        <city>Ars-laquenexy</city>
        <zip>57530</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Belharra - BAYONNE</name>
      <address>
        <city>Bayonne</city>
        <zip>64100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Vincent</name>
      <address>
        <city>Besancon</city>
        <zip>25004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de BESANCON</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé de BOIS-BERNARD</name>
      <address>
        <city>Bois-bernard</city>
        <zip>62320</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Augustin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33074</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de BORDEAUX - GH Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique Bordeaux Nord Aquitaine</name>
      <address>
        <city>Bordeaux</city>
        <zip>33300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Convert de BOURG-EN-BRESSE</name>
      <address>
        <city>Bourg-en-bresse</city>
        <zip>01000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de BREST - CH La Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HCL - Hôpital L. Pradel - BRON</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de CLERMONT-FERRAND - site Gabriel-Montpied</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de de DIJON BOURGOGNE - Hôpital François Mitterrand</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique La Ligne Bleue</name>
      <address>
        <city>Epinal</city>
        <zip>88060</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Mutualiste de GRENOBLE</name>
      <address>
        <city>Grenoble</city>
        <zip>38028</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'ARCACHON</name>
      <address>
        <city>La Teste-de-buch</city>
        <zip>33164</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM - Hôpital de La Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM - Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique Inkermann</name>
      <address>
        <city>Niort</city>
        <zip>79027</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Geoffroy St-Hilaire</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de PAU</name>
      <address>
        <city>PAU</city>
        <zip>64046</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de BORDEAUX - Hôpital Haut-Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de REIMS - Hôpital Robert Debré</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Belledonne</name>
      <address>
        <city>Saint Martin D'heres</city>
        <zip>38400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de ST-ETIENNE- Hôpital Nord</name>
      <address>
        <city>Saint-priest-en-jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HU de STRASBOURG - Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique de l'Ormeau</name>
      <address>
        <city>Tarbes</city>
        <zip>65000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de NANCY - Hôpitaux de Brabois</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Schuman</name>
      <address>
        <city>Vantoux</city>
        <zip>57070</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé de VILLENEUVE D'ASCQ</name>
      <address>
        <city>Villeneuve-d'ascq</city>
        <zip>59650</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Médipôle LYON-VILLEURBANNE</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 29, 2020</last_update_submitted>
  <last_update_submitted_qc>October 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>FEVAR</keyword>
  <keyword>Fenestrated</keyword>
  <keyword>Endovascular</keyword>
  <keyword>AAA</keyword>
  <keyword>Custom device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

